Get the Stockscreener App
293.85
0.49%
1.445
Pre-market:
292.84
-1.01
-0.34%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $293.85, with a volume of 1.95M.
It is up +0.49% in the last 24 hours and up +6.32% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$292.40
Open:
$291.745
24h Volume:
1.95M
Relative Volume:
0.87
Market Cap:
$158.20B
Revenue:
$34.76B
Net Income/Loss:
$6.62B
P/E Ratio:
24.04
EPS:
12.223
Net Cash Flow:
$10.61B
1W Performance:
-0.57%
1M Performance:
+6.32%
6M Performance:
-0.02%
1Y Performance:
-9.48%
1-Day Range:
$290.97
$296.87
1-Week Range:
$289.44
$297.62
52-Week Range:
$253.30
$335.88
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
293.85 | 157.42B | 34.76B | 6.62B | 10.61B | 12.22 |
|
LLY
Lilly Eli Co
|
812.35 | 734.56B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
190.85 | 459.75B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
229.13 | 406.84B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
130.26 | 249.96B | 53.40B | 13.68B | 16.89B | 6.8864 |
|
MRK
Merck Co Inc
|
84.70 | 214.06B | 63.43B | 16.42B | 14.72B | 6.4861 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Resumed | Raymond James | Mkt Perform |
| May-20-25 | Resumed | Guggenheim | Neutral |
| Apr-22-25 | Resumed | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Lobbying Update: $15,000 of AMGEN INC. lobbying was just disclosed - Quiver Quantitative
Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com
How forex fluctuations impact Amgen Inc. (AMG0) stock2025 Trading Recap & Consistent Growth Stock Picks - newser.com
CD40 Targeting Therapy Clinical Trials Anti CD40 Antibody Therapy Market Opportunity Assessment Insight - GlobeNewswire Inc.
Sagespring Wealth Partners LLC Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Wilmington Savings Fund Society FSB Has $15.97 Million Position in Amgen Inc. $AMGN - MarketBeat
Morningstar Investment Management LLC Makes New $1.14 Million Investment in Amgen Inc. $AMGN - MarketBeat
Alpine Woods Capital Investors LLC Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Cornerstone Wealth Group LLC Acquires 12,816 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Vest Financial LLC - MarketBeat
Amgen Inc. stock daily chart insights2025 Technical Overview & Smart Investment Allocation Tips - newser.com
(AMGN) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Short interest data insights for Amgen Inc.July 2025 Selloffs & Risk Managed Investment Signals - newser.com
Will Amgen Inc. (AMG0) stock benefit from mergers2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
Price-Driven Insight from (AMGN) for Rule-Based Strategy - news.stocktradersdaily.com
Aanika’s Journey: Life After a Severe Asthma Diagnosis - Amgen
Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention - Yahoo Finance
Understanding Momentum Shifts in (AMGN) - news.stocktradersdaily.com
Amgen Inc. $AMGN Shares Bought by Sequoia Financial Advisors LLC - MarketBeat
Concurrent Investment Advisors LLC Boosts Position in Amgen Inc. $AMGN - MarketBeat
Reflecting On Therapeutics Stocks’ Q2 Earnings: Amgen (NASDAQ:AMGN) - The Globe and Mail
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(AMGN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Will Amgen Inc. (AMG0) stock deliver stable dividendsJuly 2025 Review & Technical Pattern Recognition Alerts - newser.com
Keener Financial Planning LLC Raises Stake in Amgen Inc. $AMGN - MarketBeat
With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing - Yahoo Finance
Natural Investments LLC Has $1.05 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Cwm LLC - MarketBeat
Vanguard Personalized Indexing Management LLC Acquires 8,411 Shares of Amgen Inc. $AMGN - MarketBeat
Sather Financial Group Inc Grows Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Fifth Third Wealth Advisors LLC - MarketBeat
Richardson Financial Services Inc. Has $66,000 Position in Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation as Shares Show Renewed Momentum in the Biotech Landscape - simplywall.st
Will Amgen Inc. stock recover after recent drop2025 Support & Resistance & Consistent Profit Alerts - newser.com
Thompson Investment Management Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat
Cyndeo Wealth Partners LLC Has $6.97 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Commerzbank Aktiengesellschaft FI Sells 3,381 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Lowered by Drucker Wealth 3.0 LLC - MarketBeat
Lmcg Investments LLC Sells 2,659 Shares of Amgen Inc. $AMGN - MarketBeat
Horizon Bancorp Inc. IN Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
First Fiduciary Investment Counsel Inc. Buys 1,069 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Is Amgen Inc. (AMGN) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom? - MSN
AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing - Bioprocess Online
Market reaction to Amgen Inc.’s recent newsMarket Risk Summary & Technical Confirmation Alerts - newser.com
Responsive Playbooks and the AMGN Inflection - news.stocktradersdaily.com
Quantitative breakdown of Amgen Inc. recent moveMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Is Amgen Inc. (AMG0) stock cheap by valuation metricsTrade Volume Summary & Verified Chart Pattern Trade Signals - newser.com
Will Amgen Inc. (AMG0) stock outperform energy sector in 20252025 Winners & Losers & AI Driven Stock Reports - newser.com
Mainstay Capital Management LLC ADV Increases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Boosted by Copperwynd Financial LLC - MarketBeat
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):